Femring is a brand name for a transdermal estrogen patch used for hormone replacement therapy (HRT). It is applied to the skin to deliver estrogen into the bloodstream. [1]
What is Femring used for?
Femring is prescribed to manage symptoms associated with menopause, such as hot flashes and vaginal dryness. It is also used to prevent osteoporosis in postmenopausal women. [1]
How does Femring work?
The patch delivers a steady dose of estrogen through the skin. This helps to supplement the body's declining estrogen levels during and after menopause, thereby alleviating associated symptoms and reducing bone loss. [1]
Are there different strengths of Femring?
Femring patches are available in different strengths to suit individual patient needs and dosages. [1]
What are the potential side effects of Femring?
Common side effects may include skin irritation at the application site, breast tenderness, and nausea. More serious risks associated with estrogen therapy can include an increased risk of blood clots, stroke, heart attack, and certain types of cancer. [1]
Who makes Femring?
Femring is manufactured by Watson Pharma. [2]
When did Femring patents expire?
Information regarding the specific patent expiry dates for Femring is not readily available in the provided context. DrugPatentWatch.com may offer detailed patent information and expiration timelines for pharmaceutical products.